| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 660182 | 69434 | ENALAPRIL/ HIDROCLOROTIAZIDA PENSA 20/12,5 mg COMPRIMIDOS EFG | ENALAPRIL/ HIDROCLOROTIAZIDA PENSA 20/12,5 mg COMPRIMIDOS EFG , 28 comprimidos | 20 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69434/69434_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69434/69434_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2007-12-03 | 1 | 1 | 1 | 2007-12-03 | 2007-12-03 | 1 | 2011-06-16 | View Edit Delete | ||||||||||||
| 659610 | 69135 | TOPIRAMATO CINFA 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TOPIRAMATO CINFA 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 60 comprimidos (FRASCO) | 25 mg | 6 | 60 | 10 | 60 comprimidos (FRASCO) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69135/69135_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69135/69135_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-07-23 | 1 | 1 | 1 | 2007-07-23 | 2007-07-23 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 659612 | 69136 | TOPIRAMATO CINFA 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TOPIRAMATO CINFA 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos (FRASCO) | 50 mg | 6 | 60 | 10 | 60 comprimidos (FRASCO) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69136/69136_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69136/69136_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-07-23 | 1 | 1 | 1 | 2007-07-23 | 2007-07-23 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 659618 | 69137 | TOPIRAMATO CINFA 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TOPIRAMATO CINFA 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos (FRASCO) | 100 mg | 6 | 60 | 10 | 60 comprimidos (FRASCO) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69137/69137_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69137/69137_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-07-23 | 1 | 1 | 1 | 2007-07-23 | 2007-07-23 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 659620 | 69138 | TOPIRAMATO CINFA 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | TOPIRAMATO CINFA 200 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos (FRASCO) | 200 mg | 6 | 60 | 10 | 60 comprimidos (FRASCO) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69138/69138_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69138/69138_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-07-23 | 1 | 1 | 1 | 2007-07-23 | 2007-07-23 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 659767 | 69214 | CINFAMUCOL CARBOCISTEINA 50 mg/ml SOLUCION ORAL | CINFAMUCOL CARBOCISTEINA 50 mg/ml SOLUCION ORAL , 1 frasco de 200 ml | 50 mg/ml | 6 | 200 | 26 | 1 frasco de 200 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69214/69214_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69214/69214_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-08-08 | 1 | 1 | 1 | 2007-08-08 | 2007-08-08 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 658831 | 62133 | ZINERYT 40 MG/ML + 12 MG/ML POLVO Y DISOLVENTE PARA SOLUCIÓN CUTÁNEA | ZINERYT 40 MG/ML + 12 MG/ML POLVO Y DISOLVENTE PARA SOLUCIÓN CUTÁNEA , 1 frasco de 30 ml | 40 mg/ml + 12 mg/ml | 6 | 30 | 26 | 1 frasco de 30 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62133/62133_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62133/62133_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25535 | LABORATORIOS RUBIO S.A. | 1999-06-01 | 1 | 1 | 1 | 1999-06-01 | 1999-06-01 | 1 | 2011-10-26 | View Edit Delete | ||||||||||||
| 660113 | 03268004 | CHOLESTAGEL 625 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | CHOLESTAGEL 625 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 180 comprimidos | 625 mg | 6 | 180 | 10 | 180 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/03268004/03268004_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/03268004/03268004_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25535 | LABORATORIOS RUBIO S.A. | 2008-03-25 | 1 | 1 | 1 | 2008-03-25 | 2008-03-25 | 1 | 2011-09-06 | View Edit Delete | ||||||||||||
| 658645 | 68556 | DINAXIL 50 mg/ml SOLUCION CUTANEA | DINAXIL 50 mg/ml SOLUCION CUTANEA, 1 frasco de 60 ml | 50 mg/ml | 6 | 60 | 26 | 1 frasco de 60 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68556/68556_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68556/68556_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2616 | LABORATORIOS SERRA PAMIES S.A. | 2007-02-28 | 1 | 1 | 1 | 2007-02-28 | 2007-02-28 | 1 | 2017-11-02 | View Edit Delete | ||||||||||||
| 658646 | 68556 | DINAXIL 50 mg/ml SOLUCION CUTANEA | DINAXIL 50 mg/ml SOLUCION CUTANEA, 1 frasco de 120 ml | 50 mg/ml | 6 | 120 | 26 | 1 frasco de 120 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68556/68556_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68556/68556_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2616 | LABORATORIOS SERRA PAMIES S.A. | 2007-02-28 | 1 | 1 | 1 | 2007-02-28 | 2007-02-28 | 1 | 2017-11-02 | View Edit Delete | ||||||||||||
| 658647 | 68556 | DINAXIL 50 mg/ml SOLUCION CUTANEA | DINAXIL 50 mg/ml SOLUCION CUTANEA, 1 frasco de 180 ml | 50 mg/ml | 6 | 180 | 26 | 1 frasco de 180 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68556/68556_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68556/68556_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2616 | LABORATORIOS SERRA PAMIES S.A. | 2007-02-28 | 1 | 1 | 1 | 2007-02-28 | 2007-02-28 | 1 | 2017-11-02 | View Edit Delete | ||||||||||||
| 659042 | 68788 | OMEPRAZOL TARBIS FARMA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | OMEPRAZOL TARBIS FARMA 20 mg CAPSULAS DURAS GASTRORRESISTENTES EFG , 56 cápsulas | 20 mg | 6 | 56 | 43 | 56 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68788/68788_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68788/68788_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2007-05-11 | 1 | 1 | 1 | 2007-05-11 | 2007-05-11 | 1 | 2014-12-15 | View Edit Delete | ||||||||||||
| 659762 | 69212 | OMEPRAZOL TARBIS FARMA 10 mg CAPSULAS DURAS GASTRORRESISTENTES | OMEPRAZOL TARBIS FARMA 10 mg CAPSULAS DURAS GASTRORRESISTENTES , 28 cápsulas | 10 mg | 6 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69212/69212_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69212/69212_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2007-08-13 | 1 | 1 | 1 | 2007-08-13 | 2007-08-13 | 1 | 2011-10-21 | View Edit Delete | ||||||||||||
| 659711 | 69188 | LANSOPRAZOL VIR 15 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL VIR 15 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas | 15 mg | 6 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69188/69188_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69188/69188_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2007-07-30 | 1 | 1 | 1 | 2007-07-30 | 2007-07-30 | 1 | 2011-06-08 | View Edit Delete | ||||||||||||
| 659712 | 69189 | LANSOPRAZOL VIR 30 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL VIR 30 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 14 cápsulas | 30 mg | 6 | 14 | 43 | 14 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69189/69189_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69189/69189_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2007-07-30 | 1 | 1 | 1 | 2007-07-30 | 2007-07-30 | 1 | 2014-06-14 | View Edit Delete | ||||||||||||
| 659713 | 69189 | LANSOPRAZOL VIR 30 mg CAPSULAS DURAS GASTRORRESISTENTES EFG | LANSOPRAZOL VIR 30 mg CAPSULAS DURAS GASTRORRESISTENTES EFG, 28 cápsulas | 30 mg | 6 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69189/69189_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69189/69189_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2007-07-30 | 1 | 1 | 1 | 2007-07-30 | 2007-07-30 | 1 | 2011-06-08 | View Edit Delete | ||||||||||||
| 659079 | 68811 | CIPRALEX 20 mg/ml GOTAS ORALES EN SOLUCION | CIPRALEX 20 mg/ml GOTAS ORALES EN SOLUCION , 1 frasco de 15 ml | 20 mg/ml | 6 | 15 | 26 | 1 frasco de 15 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68811/68811_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68811/68811_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1710 | LUNDBECK ESPANA S.A. | 2007-05-23 | 1 | 1 | 1 | 2007-05-23 | 2007-05-23 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 659988 | 69328 | NASALVICKS 0,5MG/ML SOLUCION PARA PULVERIZACIÓN NASAL | NASALVICKS 0,5MG/ML SOLUCION PARA PULVERIZACIÓN NASAL , 1 envase pulverizador de 15 ml | 0,5 mg/ml | 6 | 15 | 26 | 1 envase pulverizador de 15 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69328/69328_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69328/69328_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8994 | PROCTER & GAMBLE ESPANA S.A. | 2007-10-18 | 1 | 1 | 1 | 2007-11-05 | 2007-10-18 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 658676 | 68576 | MOMETASONA MEDE 0,1% SOLUCION CUTANEA EFG | MOMETASONA MEDE 0,1% SOLUCION CUTANEA EFG, 1 frasco de 60 ml | 1 mg/g | 6 | 60 | 26 | 1 frasco de 60 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68576/68576_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68576/68576_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2367 | LABORATORIO REIG JOFRE, S.A. | 2007-03-06 | 1 | 1 | 1 | 2007-03-06 | 2007-03-06 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 659150 | 68861 | OMEPRAZOL DAVUR 40 mg CAPSULAS DURAS GASTRORRESISTENTES | OMEPRAZOL DAVUR 40 mg CAPSULAS DURAS GASTRORRESISTENTES , 28 cápsulas | 40 mg | 6 | 28 | 43 | 28 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68861/68861_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68861/68861_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2007-05-31 | 1 | 1 | 1 | 2007-05-31 | 2007-05-31 | 1 | 2011-10-24 | View Edit Delete |
Page 150 of 1035, showing 20 records out of 20689 total, starting on record 2981, ending on 3000